🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Duac

Found 35 matching trials

A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris

PHASE4

A single-blind (investigator-blinded), randomized, parallel group, single c...

Status

Completed

Location

Multiple Locations

Start Date

2009-10

Trial ID

NCT01016977

Treatments Being Tested

Clindamycin 1%/Benzoyl Peroxide 5% and 0.1% tazarotene clindamycin phosphate 1.2%/benzoyl peroxide 2.5% and 0.1% tazarotene

DUAC® Early Onset Efficacy Study in Japanese Subjects

PHASE4

This is a multicentre, randomized, single-blind (investigator is blinded), ...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-10-07

Trial ID

NCT02557399

Treatments Being Tested

Duac® fixed dose combination gel ADA 0.1% gel CLDM 1% gel

Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne

PHASE2

Benzoyl peroxide, clindamycin and tazarotene are known to be effective trea...

Status

Completed

Location

Dermatology Research of Arkansas

Start Date

2008-06

Trial ID

NCT00713609

Treatments Being Tested

Benzoyl peroxide gel Clindamycin gel Tazarotene cream Vehicle gel Vehicle cream

2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne

Acne is one of the most common conditions that patients seek for help in de...

Status

Completed

Location

Faculty of Medicine, Chulalongkorn University

Start Date

2010-10

Trial ID

NCT01472900

Treatments Being Tested

2940 nm Er:YAG laser (DualisXS M002-2A, Fotona®, Fotona d.d, Ljubljana, Slovenia)Benzoyl Peroxide gel

Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations

A randomized, double-blind, multiple-site, placebo-controlled, parallel-gro...

Status

Completed

Location

Multiple Locations

Start Date

2007-12

Trial ID

NCT01044264

Treatments Being Tested

1% Clindamycin/5% Benzoyl Peroxide Topical Gel Placebo

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

PHASE4

This is a single-blind (blinded expert grader) study that will enroll 25-30...

Status

Completed

Location

cyberDERM

Start Date

2009-08

Trial ID

NCT01015638

Treatments Being Tested

Clindamycin and BPO 5% gel Clindamycin phosphate and benzoyl peroxide 2.5% gel.

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

PHASE4

A study comparing the topical application of Aczone® plus Differin® versus ...

Status

Completed

Location

Multiple Locations

Start Date

2010-08

Trial ID

NCT01231334

Treatments Being Tested

Dapsone plus Adapalene Clindamycin/benzoyl peroxide plus Adapalene

To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

PHASE3

This is an Randomized, Double-blind, Multicentric, Parallel-group, Active a...

Status

Completed

Location

Universal BioPharma Research

Start Date

2013-11

Trial ID

NCT02005666

Treatments Being Tested

Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel DUAC® Gel Placebo

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

PHASE3

This is a randomized, double-blind, multiple-site, placebo-controlled, para...

Status

Completed

Location

Glenmark Investigational Site 13

Start Date

2015-04

Trial ID

NCT02465632

Treatments Being Tested

Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel BenzaClin® Topical Gel, Clindamycin 1%/Benzoyl Peroxide 5%Placebo

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

PHASE1

This study was conducted to determine if the bioavailability of clindamycin...

Status

Completed

Location

Multiple Locations

Start Date

2010-05-06

Trial ID

NCT01132443

Treatments Being Tested

Clindamycin 1%-Benzoyl Peroxide (BPO) 3% Gel,

Previous Next